Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Current issues in the management of acute promyelocytic leukemia.

Slack JL, Rusiniak ME.

Ann Hematol. 2000 May;79(5):227-38. Review.

PMID:
10870476
2.

[Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].

Chen SJ, Chen LJ, Zhou GB.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):1-8. Chinese.

PMID:
15748426
3.

The molecular biology of acute promyelocytic leukemia.

Slack JL, Gallagher RE.

Cancer Treat Res. 1999;99:75-124. Review.

PMID:
9891864
4.

The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease.

Mistry AR, Pedersen EW, Solomon E, Grimwade D.

Blood Rev. 2003 Jun;17(2):71-97. Review.

PMID:
12642121
5.

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.

Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F.

Blood. 1996 Aug 15;88(4):1390-8.

6.

Acute promyelocytic leukemia: from clinic to molecular biology.

Chen SJ, Wang ZY, Chen Z.

Stem Cells. 1995 Jan;13(1):22-31. Review.

PMID:
7719245
7.

Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.

Chen Z, Chen SJ, Wang ZY.

C R Acad Sci III. 1994 Dec;317(12):1135-41. Review.

PMID:
7697468
8.

Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.

Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.

Oncogene. 1995 Jun 15;10(12):2307-14.

PMID:
7784078
9.

Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.

Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA, Dmitrovsky E.

Differentiation. 1997 Aug;61(5):321-31.

PMID:
9342843
10.

Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.

Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K.

Blood. 1998 Jul 15;92(2):374-82.

12.

Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.

Zhang JW, Wang JY, Chen SJ, Chen Z.

J Biosci. 2000 Sep;25(3):275-84. Review.

PMID:
11022230
13.

The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.

Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F, et al.

Oncogene. 1994 Feb;9(2):545-51.

PMID:
8290265
14.

Advances in therapies for acute promyelocytic leukemia.

Kamimura T, Miyamoto T, Harada M, Akashi K.

Cancer Sci. 2011 Nov;102(11):1929-37. doi: 10.1111/j.1349-7006.2011.02045.x. Epub 2011 Aug 24. Review.

15.

Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis.

Chen Z, Wang ZY, Chen SJ.

Pharmacol Ther. 1997 Oct-Dec;76(1-3):141-9. Review.

PMID:
9535176
16.

Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.

Grimwade D, Solomon E.

Curr Top Microbiol Immunol. 1997;220:81-112. Review.

PMID:
9103677
17.
18.

Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.

Chen Z, Tong JH, Dong S, Zhu J, Wang ZY, Chen SJ.

Genes Chromosomes Cancer. 1996 Mar;15(3):147-56. Review.

PMID:
8721678
20.

Acute promyelocytic leukemia: recent advances in diagnosis and management.

Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA.

Semin Oncol. 2008 Aug;35(4):401-9. doi: 10.1053/j.seminoncol.2008.04.010.

PMID:
18692690

Supplemental Content

Support Center